Diabetes complications

High-Frequency 10-kHz Spinal Cord Stimulation Provides Long-term (24-Month) Improvements in Diabetes-Related Pain and Quality of Life for Patients with Painful Diabetic Neuropathy

J Diabetes Sci TechnolPublished Secondary analysis of the SENZA-PDN randomised trial

Authors' conclusion

High-frequency 10-kHz SCS significantly decreased pain severity and provided additional clinically meaningful improvements in DQOL and overall functioning for patients with PDN. The robust and sustained benefits over 24 months, coupled with high participant satisfaction, highlight that 10-kHz SCS is an efficacious and comprehensive therapy for patients with PDN.

Study context

Population
Participants with refractory painful diabetic neuropathy (PDN)142 completed 24-month assessments
Participants
216 participants
Comparison
10-kHz spinal cord stimulation (SCS) + conventional medical management (CMM) vs CMM
Methodological detailscrossover allowed after six months
  • Crossover allowed after six months

Primary result

As reported in the abstract

24 months
Reduction in pain severity (Brief Pain Inventory for Diabetic Peripheral Neuropathy (BPI-DPN))
66.9% (P < .001)
Reduction in pain interference with mood and daily activities (BPI-DPN)
65.8% (P < .001)
Significant improvement in overall DQOL score
P < .001
Significant improvement in Global Assessment of Functioning (GAF) score
P < .001

Further findings

Treatment satisfaction · 24 months

Participants satisfied with treatment
91.5%

Original publication

High-Frequency 10-kHz Spinal Cord Stimulation Provides Long-term (24-Month) Improvements in Diabetes-Related Pain and Quality of Life for Patients with Painful Diabetic Neuropathy. J Diabetes Sci Technol. Published 6 October 2024. doi:10.1177/19322968241268547

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.